IP Verse

Aventis Pharma competitive analysis

Loading summary...

Latest patents of Aventis Pharma opposed by its competitors

Explore Aventis Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2493466
Mar 10, 2021Novel Antitumoral Use Of Cabazitaxel13
EP3294285
Dec 18, 2019Cabazitaxel And Its Use For Treating Cancer10
EP2678011
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And Cisplatin1

Latest publications and patents of Aventis Pharma New

Explore the latest publications and patents granted to Aventis Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Aventis Pharma

EP2493466
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelOpposition Rejected
EP3294285
Dec 18, 2019Cabazitaxel And Its Use For Treating CancerRevoked
EP2678011
Jun 26, 2019Antitumoral Combination Comprising Cabazitaxel And CisplatinRevoked

Latest PTAB cases involving Aventis Pharma

Discover the latest PTAB cases involving Aventis Pharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Aventis Pharma

IPR2019-00136Oct 31, 2018NEPTUNE GENERICSAVENTIS PHARMAInstitution Denied
IPR2016-00712Mar 15, 2016MYLAN LABORATORIESAVENTIS PHARMAFinal Written Decision
IPR2016-00627Feb 17, 2016MYLAN LABORATORIESAVENTIS PHARMAInstitution Denied

Peer Comparison New

IP litigation analysis comparing Aventis Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
AVENTIS PHARMA - 24 - 3
ACCORD HEALTHCARE39 - 4 -
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTEL6 - - -
GENERICS UK214 - - -